{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:55:22Z","timestamp":1789779322052,"version":"4.0.1"},"reference-count":43,"publisher":"The Endocrine Society","issue":"7","funder":[{"DOI":"10.13039\/100000062","name":"Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-producing neuroendocrine tumors with significant systemic effects. While catecholamine-related cardiovascular manifestations are well-characterized as a prominent component of the clinical presentation, other systemic effects, particularly those on bone and mineral metabolism, remain much less characterized. Bone physiology and health in patients with PPGLs can be affected through catecholamine-mediated changes, skeletal metastases, or specific skeletal abnormalities associated with syndromic PPGL forms. The catecholamine effect on bone density was first noticed in experimental murine models, where \u03b2-adrenoceptor signaling was shown to increase bone resorption. These findings were further supported by epidemiological and translational studies indicating a protective role of \u03b2-adrenoceptor blockers in maintaining bone density. Both preclinical and clinical studies draw attention to the potential alterations of bone physiology in patients with PPGLs. To date, a few retrospective studies have evaluated bone turnover markers and bone mineral density (BMD) in these patients, consistently showing lower BMD and trabecular bone score, as well as elevated serum C-terminal telopeptides levels, compared to healthy controls with partial reversibility following surgical resection of the tumor. In this review, we summarize the available mechanistic and clinical literature on bone health in PPGLs, to raise awareness among clinicians, identify opportunities for primary prevention, and ensure a better quality of life.<\/jats:p>","DOI":"10.1210\/clinem\/dgag069","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:47:10Z","timestamp":1771418830000},"page":"1813-1819","source":"Crossref","is-referenced-by-count":2,"title":["Effects of catecholamines on bone and mineral metabolism in patients with pheochromocytoma and paraganglioma"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0861-9348","authenticated-orcid":false,"given":"Hussam","family":"Alkaissi","sequence":"first","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-3767","authenticated-orcid":false,"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Center for Adrenal Endocrine Tumors, AKESO , Prague 5 155 00 ,","place":["Czech Republic"]},{"name":"Multidisciplinary Consortium for Adrenal Diseases, Palacky University , Olomouc 779 00 ,","place":["Czech Republic"]},{"name":"Faculty of Medicine, 5th Department of Medicine, Comenius University , Bratislava 814 99 ,","place":["Slovak Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8988-7186","authenticated-orcid":false,"given":"Catherine M","family":"Gordon","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"12","key":"2026061619575353000_dgag069-B1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.eprac.2022.09.003","article-title":"New biology of pheochromocytoma and paraganglioma","volume":"28","author":"Pacak","year":"2022","journal-title":"Endocr Pract"},{"issue":"4","key":"2026061619575353000_dgag069-B2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American neuroendocrine tumor society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"3","key":"2026061619575353000_dgag069-B3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/cancers14030594","article-title":"New insights on the genetics of pheochromocytoma and paraganglioma and its clinical implications","volume":"14","author":"Jhawar","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"17","key":"2026061619575353000_dgag069-B4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djt201","article-title":"Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction","volume":"105","author":"Jochmanova","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2026061619575353000_dgag069-B5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"2026061619575353000_dgag069-B6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1210\/jc.2015-3205","article-title":"Genotype-dependent brown adipose tissue activation in patients with pheochromocytoma and paraganglioma","volume":"101","author":"Puar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026061619575353000_dgag069-B7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12020-025-04260-5","article-title":"Pathophysiology and evaluation of bone health in adrenal diseases","volume":"89","author":"Uygur","year":"2025","journal-title":"Endocrine"},{"key":"2026061619575353000_dgag069-B8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bonr.2018.11.002","article-title":"Cortical bone is an extraneuronal site of norepinephrine uptake in adult mice","volume":"9","author":"Zhu","year":"2018","journal-title":"Bone Rep"},{"issue":"1","key":"2026061619575353000_dgag069-B9","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1038\/s41467-023-38616-0","article-title":"Neutrophil-derived catecholamines mediate negative stress effects on bone","volume":"14","author":"Tschaffon-Muller","year":"2023","journal-title":"Nat Commun"},{"issue":"9","key":"2026061619575353000_dgag069-B10","doi-asserted-by":"crossref","first-page":"e0138347","DOI":"10.1371\/journal.pone.0138347","article-title":"Effects of age and estrogen on skeletal gene expression in humans as assessed by RNA sequencing","volume":"10","author":"Farr","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"2026061619575353000_dgag069-B11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0169-6009(08)80105-5","article-title":"Characterization of Beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that Beta-receptor agonists can stimulate bone-resorption in organ-culture","volume":"23","author":"Moore","year":"1993","journal-title":"Bone Miner"},{"issue":"4","key":"2026061619575353000_dgag069-B12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/en.2010-0881","article-title":"\u03b22-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone","volume":"152","author":"Ma","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"2026061619575353000_dgag069-B13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jcb.24953","article-title":"PTH regulates \u03b22-Adrenergic receptor expression in osteoblast-like MC3T3-E1 cells","volume":"116","author":"Moriya","year":"2015","journal-title":"J Cell Biochem"},{"issue":"19","key":"2026061619575353000_dgag069-B14","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1073\/pnas.1109036109","article-title":"Anabolic action of parathyroid hormone regulated by the beta2-adrenergic receptor","volume":"109","author":"Hanyu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026061619575353000_dgag069-B15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/en.2008-0843","article-title":"Mice lacking \u03b2-Adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of Ovariectomy","volume":"150","author":"Bouxsein","year":"2009","journal-title":"Endocrinology"},{"issue":"18","key":"2026061619575353000_dgag069-B16","doi-asserted-by":"crossref","first-page":"e2207602","DOI":"10.1002\/advs.202207602","article-title":"Sympathetic innervation regulates osteocyte-mediated cortical bone resorption during lactation","volume":"10","author":"Guo","year":"2023","journal-title":"Adv Sci"},{"issue":"6","key":"2026061619575353000_dgag069-B17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jbmr.1594","article-title":"Deletion of \u03b2-Adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation","volume":"27","author":"Pierroz","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026061619575353000_dgag069-B18","doi-asserted-by":"crossref","first-page":"e10712","DOI":"10.1002\/jbm4.10712","article-title":"Beta 2 Adrenergic receptor selective antagonist enhances mechanically stimulated bone anabolism in aged mice","volume":"7","author":"E. Worton","year":"2023","journal-title":"Jbmr Plus"},{"key":"2026061619575353000_dgag069-B19","doi-asserted-by":"crossref","first-page":"174515","DOI":"10.1016\/j.ejphar.2021.174515","article-title":"Beta1-Adrenergic receptor but not beta2 mediates osteogenic differentiation of bone marrow mesenchymal stem cells in normotensive and hypertensive rats","volume":"911","author":"Alves Barreto","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2026061619575353000_dgag069-B20","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1002\/jcb.27998","article-title":"Selective beta2-adrenoreceptor signaling regulates osteoclastogenesis via modulating RANKL production and neuropeptides expression in osteocytic MLO-Y4 cells","volume":"120","author":"Liang","year":"2019","journal-title":"J Cell Biochem"},{"issue":"5","key":"2026061619575353000_dgag069-B21","first-page":"E507","article-title":"\u03b2-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species","volume":"304","author":"Kondo","year":"2013","journal-title":"Am J Physiol-Endoc M"},{"issue":"3","key":"2026061619575353000_dgag069-B22","doi-asserted-by":"crossref","first-page":"e2100763","DOI":"10.1002\/smtd.202100763","article-title":"Sympathetic neurostress drives osteoblastic exosomal MiR-21 transfer to disrupt bone homeostasis and promote osteopenia","volume":"6","author":"Hu","year":"2022","journal-title":"Small Methods"},{"issue":"2","key":"2026061619575353000_dgag069-B23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jbmr\/zjae200","article-title":"Pharmacogenetic and microRNA mechanisms of beta blocker use on bone","volume":"40","author":"Lary","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026061619575353000_dgag069-B24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2350-7-57","article-title":"Beta3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)","volume":"7","author":"Wang","year":"2006","journal-title":"BMC Med Genet"},{"issue":"3","key":"2026061619575353000_dgag069-B25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S8756-3282(98)00099-4","article-title":"Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells","volume":"23","author":"Suzuki","year":"1998","journal-title":"Bone"},{"issue":"5","key":"2026061619575353000_dgag069-B26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0006-2952(00)00591-8","article-title":"Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells","volume":"61","author":"Takeuchi","year":"2001","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2026061619575353000_dgag069-B27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00198-015-3312-x","article-title":"Clonidine increases bone resorption in humans","volume":"27","author":"Limonard","year":"2016","journal-title":"Osteoporosis Int"},{"key":"2026061619575353000_dgag069-B28","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.12659\/MSM.908376","article-title":"Association of adrenergic receptor alpha2A (alpha2A-AR) gene rs1800544 polymorphism with bone mineral density and bone turnover markers in an elderly Chinese population","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci Monit"},{"issue":"11","key":"2026061619575353000_dgag069-B29","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","article-title":"Use of \u03b2-blockers and risk of fractures","volume":"292","author":"Schlienger","year":"2004","journal-title":"JAMA-J Am Med Assoc"},{"issue":"11","key":"2026061619575353000_dgag069-B30","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1172\/JCI122151","article-title":"Sympathetic \u03b2-Adrenergic signaling contributes to regulation of human bone metabolism","volume":"128","author":"Khosla","year":"2018","journal-title":"J Clin Invest"},{"key":"2026061619575353000_dgag069-B31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bone.2014.10.024","article-title":"The effects of beta-2 Adrenergic agonist and antagonist on human bone metabolism: a randomized controlled trial","volume":"71","author":"Veldhuis-Vlug","year":"2015","journal-title":"Bone"},{"issue":"4","key":"2026061619575353000_dgag069-B32","doi-asserted-by":"crossref","first-page":"101792","DOI":"10.1016\/j.ando.2025.101792","article-title":"Bone, a double victim in metastatic catecholamine secreting tumors","volume":"86","author":"Jannin","year":"2025","journal-title":"Ann Endocrinol (Paris)"},{"issue":"10","key":"2026061619575353000_dgag069-B33","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/clinem\/dgaf259","article-title":"Approach to the patient with metastatic pheochromocytoma and paraganglioma","volume":"110","author":"Alkaissi","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026061619575353000_dgag069-B34","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2012-2823","article-title":"Bone resorption is increased in pheochromocytoma patients and normalizes following adrenalectomy","volume":"97","author":"Veldhuis-Vlug","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026061619575353000_dgag069-B35","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2017-00169","article-title":"Lower bone mass and higher bone resorption in pheochromocytoma: importance of sympathetic activity on human bone","volume":"102","author":"Kim","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061619575353000_dgag069-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2018.06.023","article-title":"Higher sympathetic activity as a risk factor for skeletal deterioration in pheochromocytoma","volume":"116","author":"Kim","year":"2018","journal-title":"Bone"},{"key":"2026061619575353000_dgag069-B37","doi-asserted-by":"crossref","first-page":"115221","DOI":"10.1016\/j.bone.2020.115221","article-title":"Pheochromocytoma and paraganglioma: an emerging cause of secondary osteoporosis","volume":"133","author":"Yokomoto-Umakoshi","year":"2020","journal-title":"Bone"},{"issue":"11","key":"2026061619575353000_dgag069-B38","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00198-020-05527-5","article-title":"Coexistence of osteoporosis and atherosclerosis in pheochromocytoma: new insights into its long-term management","volume":"31","author":"Yokomoto-Umakoshi","year":"2020","journal-title":"Osteoporosis Int"},{"key":"2026061619575353000_dgag069-B39","doi-asserted-by":"crossref","first-page":"115607","DOI":"10.1016\/j.bone.2020.115607","article-title":"Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma","volume":"142","author":"Yokomoto-Umakoshi","year":"2021","journal-title":"Bone"},{"issue":"3","key":"2026061619575353000_dgag069-B40","doi-asserted-by":"crossref","first-page":"101501","DOI":"10.1016\/j.jocd.2024.101501","article-title":"Impact of pheochromocytoma or paraganglioma on bone metabolism: a systemic review and meta-analysis","volume":"27","author":"Dutta","year":"2024","journal-title":"J Clin Densitom"},{"issue":"1","key":"2026061619575353000_dgag069-B41","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/s41467-025-57595-y","article-title":"Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles","volume":"16","author":"Flynn","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"2026061619575353000_dgag069-B42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EC-20-0163","article-title":"Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study","volume":"9","author":"Larsen","year":"2020","journal-title":"Endocr Connect"},{"issue":"3","key":"2026061619575353000_dgag069-B43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","article-title":"An overview of the use of the Fracture Risk Assessment Tool (FRAX) in osteoporosis","volume":"47","author":"Schini","year":"2024","journal-title":"J Endocrinol Invest"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag069\/67007900\/dgag069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/1813\/67007900\/dgag069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/1813\/67007900\/dgag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:58:02Z","timestamp":1781654282000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/7\/1813\/8492661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag069","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,19]]}}}